http://news.prlog.org/tag/biotech/biotech - Latest News (Press Releases) - Read news before it's newsen-us3600 http://www.prlog.org/11802287-industry-leaders-come-together-at-3rd-annual-india-leadership-conclave-to-brainstorm-on-brand-india.htmlM.D. Mallya , Gopinath , Sushil Karwa , Ajit Joshi , Dr Kannan Vishwanathan , Vijay Kalantri , Paritosh Joshi , Shailendra Singh , Dr BR Jagashetty,,François Licoppe ,Naveen Surya & Ashish Agarwal are among those to address at Conclave 2012Sat, 18 Feb 2012 03:56:49 GMT http://www.prlog.org/11799696-the-patent-expiry-of-blockbuster-biologics-to-create-opportunities-in-the-european-biosimilar-market.htmlSeamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth MarketWed, 15 Feb 2012 13:44:30 GMT http://www.prlog.org/11796209-new-data-on-mentrik-biotechs-ocaratuzumab-ame-133v-published-in-clinical-cancer-research.htmlNew pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.Fri, 10 Feb 2012 22:11:44 GMT http://www.prlog.org/11795038-efib-european-forum-for-industrial-biotechnology-2012-call-for-papers.htmlEuropaBio and IntetechPira announce call for papers for EFIB 2012 - the European Forum for Industrial Biotechnology and the Biobased economy.Thu, 09 Feb 2012 18:44:41 GMT http://www.prlog.org/11792904-chi-announces-challenges-of-targeting-cancer-stem-cells-at-cancer-biologics-2012.htmlJoin us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.Tue, 07 Feb 2012 21:03:16 GMT http://www.prlog.org/11792453-tick-approval-for-hpv-superbug-busting-technology.htmlThe latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. Targeted at the life sciences and healthcare markets, this unique methodology is used to eradicate microbes.Tue, 07 Feb 2012 14:16:22 GMT http://www.prlog.org/11790899-cmci-is-invited-to-attend-the-fourth-annual-meeting-of-holstein-dairy-farmers-club.htmlThrough attending the annual meeting, CMCI has given excellent impressions on cow-breeding companies, and is expected to seek for further development opportunities.Mon, 06 Feb 2012 06:42:49 GMT http://www.prlog.org/11789466-pharma-iq-publish-big-pharma-global-recession-report-444-fear-redundancy-in-2012.htmlIndustry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.comFri, 03 Feb 2012 14:28:58 GMT http://www.prlog.org/11784562-us-army-incorporates-proactive-solution-to-bacteria.htmlU.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria …Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application …Sun, 29 Jan 2012 21:50:16 GMT http://www.prlog.org/11782678-chi-announces-technological-challenges-with-antibody-drug-conjugates-at-cancer-biologics-2012.htmlA roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.Thu, 26 Jan 2012 19:20:00 GMT http://www.prlog.org/11779001-frost-sullivan-rising-interest-of-big-pharma-creates-immense-growth-potential-for-cmos.htmlTechnical Expertise, Potential for Time and Cost Savings Underlines Viability of Contract OutsourcingMon, 23 Jan 2012 11:34:31 GMT http://www.prlog.org/11776706-chi-announces-pre-clinical-assessment-for-prediction-of-clinical-success-for-cancer-biologics.htmlA roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.Thu, 19 Jan 2012 18:32:00 GMT http://www.prlog.org/11775732-cambridge-healthtech-institute-announces-featured-presentations-at-cancer-biologics-2012.htmlCHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.Wed, 18 Jan 2012 19:05:00 GMT http://www.prlog.org/11773222-peptides-international-announces-new-management-structure.htmlPeptides International announces new management structure, including new President and Chief Operating officers, and Vice President, following very successful year and expanded opportunities, especially in custom peptide synthesis.Mon, 16 Jan 2012 14:21:16 GMT http://www.prlog.org/11770888-plenary-keynote-line-up-at-the-upcoming-molecular-medicine-tri-conference.htmlHear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-ConferenceThu, 12 Jan 2012 20:36:45 GMT http://www.prlog.org/11767982-tcd-pharma-announces-15m-equity-investment-by-ade-capital-sodical-scr.htmlThe funds will enable the Company to continue the development of TCD-717, its leading product currently in a Phase I clinical trial for the treatment of cancer, as well as expanding its pipeline.Wed, 11 Jan 2012 19:34:00 GMT http://www.prlog.org/11769606-lifesensors-announces-new-director-of-sales-and-marketing.htmlLifeSensors, Inc. announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director.Wed, 11 Jan 2012 17:20:56 GMT http://www.prlog.org/11769610-the-south-west-water-approach-what-to-look-out-for-in-data-management-in-2012.htmlKim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives through smarter and more efficient data managementWed, 11 Jan 2012 17:16:14 GMT http://www.prlog.org/11768685-signablok-awarded-darpa-contract-to-support-new-technology-to-combat-sepsis.htmlSignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning).Tue, 10 Jan 2012 20:44:10 GMT http://www.prlog.org/11767512-chi-announces-its-roadmap-for-accelerating-commercialization-of-molecular-diagnostics-short-course.htmlCHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco.Tue, 10 Jan 2012 15:20:00 GMT